Yarrow Bioscience, Inc. (YARW)
40.50
+1.25
(+3.18%)
USD |
NASDAQ |
Aug 26, 11:22
Yarrow Bioscience Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.0006 |
| March 31, 2025 | 0.0014 |
| December 31, 2024 | 0.0019 |
| September 30, 2024 | 0.0019 |
| June 30, 2024 | 0.0019 |
| March 31, 2024 | 0.0022 |
| December 31, 2023 | 0.0024 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.0006 |
| March 31, 2022 | 0.0021 |
| December 31, 2021 | 0.0072 |
| September 30, 2021 | 0.0179 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.4623 |
| March 31, 2021 | 0.3736 |
| December 31, 2020 | 0.9277 |
| September 30, 2020 | 0.711 |
| June 30, 2020 | 0.4959 |
| March 31, 2020 | 0.4969 |
| December 31, 2019 | 1.961 |
| September 30, 2019 | 0.0099 |
| June 30, 2019 | 0.0099 |
| March 31, 2019 | 0.0059 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Oramed Pharmaceuticals, Inc. | 0.0023 |
| NRX Pharmaceuticals, Inc. | -7.329 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 23.60M |
| Total Liabilities (Quarterly) | 1.542M |
| Shareholders Equity (Quarterly) | 22.06M |
| Current Ratio | 15.26 |
| Net Debt Paydown Yield | 0.06% |